Clinical Trial Update: Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating cisplatin, docetaxel, and S-1 for advanced gastric cancer and gastroesophageal junction cancer. The trial status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | Status: UNKNOWN